Table I.
Baseline characteristics of subjects
| Characteristic | Treatment group | Control group | P-value |
|---|---|---|---|
| Number | 42 | 48 | _ |
| Male sex (%) | 66.7 | 68.8 | 0.83 |
| Age [years] | 77.5 ±10.2 | 79 ±9.2 | 0.76 |
| BMI [kg/m2] | 25.4 ±2.2 | 24.6 ±2.5 | 0.84 |
| Diabetes mellitus (%) | 54.8 | 54.2 | 0.96 |
| Hypertension (%) | 85.7 | 83.3 | 0.76 |
| Dyslipidemia (%) | 83.3 | 66.7 | 0.07 |
| Cardiovascular disease (%) | 47.6 | 52.1 | 0.67 |
| FT3 [pmol/l] | 4.62 ±1.27 | 4.85 ±1.42 | 0.89 |
| FT4 [pmol/l] | 16.85 ±2.84 | 18.62 ±2.78 | 0.88 |
| TSH [mIU/l] | 13.72 ±2.29 | 7.09 ±1.23 | < 0.01 |
| TPOAb ≥ 60 IU/ml (%) | 28.6 | 0 | _ |
| SCr [mg/dl] | 136.8 ±25.5 | 136.1 ±23.7 | 0.89 |
| eGFR [ml/min/1.73 m2] | 43.4 ±6.1 | 42.8 ±5.9 | 0.62 |
The data are presented as the mean ± SD or as the percentage. The eGFR was calculated using the CKD-EPI equation.